SRPTW Financials 07/16/2014 01:30:32 Sarepta Ther
Post# of 3
Sarepta Therapeutics, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 14,219 37,329 46,990 29,420
Cost of Revenue - - - -
Gross Profit 14,219 37,329 46,990 29,420
Operating Expenses
Research and Development 72,909 52,402 66,862 35,972
Sales, General and Admin. 31,594 14,630 16,055 14,382
Non-Recurring Items - - - -
Other - - - -
Operating Income (90,284) (29,703) (35,927) (20,934)
Income From Continuing Operations
Add'l Income/Expense Items (22,027) (91,938) 33,022 (11,243)
Earnings Before Interest and Tax (111,985) (121,287) (2,318) (32,177)
Interest Expense - - - -
Earnings Before Tax (111,985) (121,287) (2,318) (32,177)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (111,985) (121,287) (2,318) (32,177)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (111,985) (121,287) (2,318) (32,177)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (111,985) (121,287) (2,318) (32,177)